The issue is, words are cheap.
Submissions to attempt to recover interest have been months in the making. There is also zero chance that they get any interest. The judgment was abundantly clear.
Resumption of dividends is good. Critical even. But it is now caveated by ‘if we get substantial cash’. If they are relying on the mesh interest for that, then there will be no dividend.
Their confidence in achieving greater cash generation is wonderful, but as I said, words are cheap. They have missed many targets before.
Worryingly, there is no mention of the balance of the mesh costs which should be due, and sizeable. Around $20m. I have concerns that it will be no where near that amount.
I completely agree that management will need to deliver on what they have said to regain investor trust. The two month run into 31 December is critical. The last thing investors want to see in the half year is more excuses for delayed cash generation.
- Forums
- ASX - By Stock
- Ann: AGM Chairman's Address and MD & CEO's Presentation
SHJ
shine justice ltd
Add to My Watchlist
0.00%
!
71.0¢

The issue is, words are cheap. Submissions to attempt to recover...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
71.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $120.5M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 750 | 68.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
71.0¢ | 394 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 750 | 0.680 |
1 | 1538 | 0.650 |
1 | 1564 | 0.640 |
4 | 8928 | 0.620 |
1 | 1625 | 0.615 |
Price($) | Vol. | No. |
---|---|---|
0.710 | 394 | 1 |
0.740 | 7710 | 1 |
0.750 | 7527 | 2 |
0.775 | 15000 | 1 |
0.780 | 15000 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
SHJ (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online